Companies / Fate Therapeutics Inc

Fate Therapeutics Inc

Nasdaq: FATECIK 1434316SAN DIEGO, CAfatetherapeutics.com ↗

Financials · FY2025

Revenue$6.65M
Net income$-136.31M
Total debt$9.47M
Cash$32.43M
Diluted EPS$-1.15
Shares outstanding119.8M

Ownership

119.8M shares outstanding · as of Aug 6, 2026
1.1%Insiders
Ownership
Insiders1.11%1,324,451
Institutions60.06%71,965,418
Public float38.83%46,530,645

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Valamehr BahramCEOPresident and CEO · Director
0.55%664,708
Tahl CindySee Remarks
0.41%487,081
Adawi KamalChief Financial Officer
0.08%100,000
Epstein Robert SDirector
0.03%36,331
Rastetter William HDirector
0.03%36,331

Institutional holders 146

View all →
HolderValue% of shares
BlackRock, Inc.$19.71M6.09%
Redmile Group, LLC$12.65M10.74%
Vanguard Group Inc$8.82M7.49%
Two Sigma Investments, LP$4.16M2.89%
AQR Capital Management, LLC$3.60M2.51%
Renaissance Technologies LLC$3.57M2.48%
Johnson & Johnson$3.32M2.82%
Geode Capital Management, LLC$3.11M2.16%
Vestal Point Capital, LP$1.69M1.44%
Two Sigma Advisers, LP$1.62M1.38%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
TrimCommon stock$-7.77M-2.9M
-28.28%
7,298,895
6.09% of shares
medium
Q2 2026
as of
State Street Corporation
13F manager
TrimCommon stock$-4.61M-1.7M
-75.33%
558,928
0.47% of shares
low
Q1 2026
as of
AQR Capital Management, LLC
13F manager
AddCommon stock$2.21M+1.8M
+158.31%
3,001,521
2.51% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddCommon stock$2.08M+1.7M
+99.92%
3,466,786
2.89% of shares
low
Q1 2023
as of
Barclays PLC
13F manager
AddCommon stock$1.35M+237K
+89.80%
500,822
0.42% of shares
low
Q3 2024
as of
Barclays PLC
13F manager
AddCommon stock$1.05M+301K
+245.26%
424,277
0.35% of shares
low
Q4 2023
as of
Barclays PLC
13F manager
AddCommon stock$899.9K+241K
+202.63%
359,375
0.30% of shares
low
Q2 2026
as of
Monaco Asset Management SAM
13F manager
ExitCommon stock$-815.6K-830K
-100.00%
0
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
FATE——31189P102—